Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

A tool to help cancer patients overcome travel challenges for radiation therapy

Official title: Testing the Feasibility of a Transportation for Cancer Care Navigation Tool (TRACT) in Solid Tumors Patients Receiving Radiotherapy

Run by Emory University · NCT06541158 · Data updated 2026-11-12

This study is testing a new tool to help cancer patients with solid tumors get to their radiation therapy appointments more easily and see if it helps them stick to their treatment better.

More Malignant Solid Neoplasm trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment76 (estimated)
SponsorEmory University
Academic / other
Drugs / interventionschemotherapy, radiation
Locations4 sites (Atlanta, Georgia and 3 other locations)
StatusRecruiting
StartedNovember 6, 2024
Main results expectedMay 15, 2028
Study endsMay 15, 2028
Registry record updatedMay 28, 2026
Trial IDNCT06541158 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older diagnosed with solid tumors who are undergoing radiation therapy and experience travel barriers.

Probably not a fit

Patients receiving palliative care or those with major depression/anxiety disorders that interfere with participation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the Transportation for Cancer Care Navigation Tool (TRACT) aimed at reducing travel barriers for patients with solid tumors undergoing radiation therapy. The study involves collaboration with a Community Advisory Board to refine the TRACT program, which includes screening for travel barriers, providing resources, and personalized transportation support. Patients will be randomized into two groups: one receiving the TRACT program and the other receiving standard care with additional informational resources. The trial will assess the feasibility and efficacy of the TRACT program on treatment adherence and patient-reported outcomes over a follow-up period of three months.

Why it matters

Potential benefit: If successful, this program could significantly improve treatment adherence and quality of life for cancer patients facing transportation challenges.

How similar studies have gone: While similar approaches to addressing travel barriers in cancer care have been explored, the TRACT program represents a novel intervention specifically tailored for patients undergoing radiation therapy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Diagnosed with solid tumors
* Undergoing RT (not excluded with chemotherapy)
* Competent to give consent
* English-speaking
* With travel barriers as screened by the reliable and validated 10-item Transportation Barriers Measure. In this study, item 2 ("how much trouble is it for you to get transportation to your doctor or treatment?") from the general barriers domain will be used to screen patients for travel barriers

Exclusion Criteria:

* Receive palliative care
* Are non-English-speaking (excluded due to pilot data without fund to support translation services)
* Are enrolled in lodging programs (e.g., the American Cancer Society \[ACS\] Hope Lodge®)
* Have major depression/anxiety disorders that interfere with their ability to participate (based on the electronic medical records report)

Where it's running

  • Emory University Hospital Midtown
    Atlanta, Georgia, United States
    Recruiting
  • Emory University Hospital/Winship Cancer Institute
    Atlanta, Georgia, United States
    Recruiting
  • Emory Saint Joseph's Hospital
    Atlanta, Georgia, United States
    Recruiting
  • Emory Proton Therapy Center
    Atlanta, Georgia, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Jinbing Bai — Emory University Hospital/Winship Cancer Institute

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.